Lalwani Nikhil
SEC CIK 1822629 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANIP | ANI PHARMACEUTICALS INC | Pres, CEO, Dir | 339.1K | $200.0K | $19.96M | 35 | 2021-09-08 | 2026-09-15 |
Most active insiders at ANIP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lalwani Nikhil | Pres, CEO, Dir | — | $5.05M |
| 2 | Walsh Patrick D | Dir | — | $2.32M |
| 3 | CAREY STEPHEN P. | SVP, CFO | — | $1.78M |
| 4 | Mutz Christopher | HEAD OF RARE DISEASE | — | $1.64M |
| 5 | Gassert Chad | SVP - CORP. DEV, STRATEGY | — | $1.31M |
| 6 | Davis Krista | SVP, Chief HR Off | — | $918.6K |
| 7 | Gutwerg Ori | SVP, GENERICS | — | $621.4K |
| 8 | Cook Meredith | SVP, GC, SEC | — | $453.9K |
| 9 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | — | $393.8K |
| 10 | HAUGHEY THOMAS | Dir | — | $161.8K |
Transactions 35
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-16 16:20 | 2026-09-15 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | S - Sale | $71.00 | -5,400 | 339.1K | -2% | -$383.4K |
| T | 2026-08-26 18:15 | 2026-08-25 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | S - Sale | $74.30 | -5,400 | 344.5K | -2% | -$401.2K |
| 2026-05-13 16:16 | 2026-05-11 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | S - Sale | $77.57 | -55.0K | 349.9K | -14% | -$4.27M | |
| 2026-03-10 | 2026-03-07 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $74.04 | -17.1K | 404.9K | -4% | -$1.26M | |
| 2026-03-02 | 2026-02-28 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $73.90 | -12.2K | 421.9K | -3% | -$902.8K | |
| 2026-03-02 | 2026-02-26 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | A - Grant | $77.15 | +75.6K | 434.2K | +21% | +$5.83M | |
| M | 2026-02-17 | 2026-02-12+ | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $77.01 | -22.0K | 358.6K | -6% | -$1.69M |
| 2026-02-13 | 2026-02-11 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $76.25 | -30.7K | 380.6K | -7% | -$2.34M | |
| 2025-08-14 | 2025-08-12 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | S - Sale | $85.93 | -57.0K | 411.2K | -12% | -$4.89M | |
| 2025-03-25 | 2025-03-23 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $64.26 | -17.5K | 468.2K | -4% | -$1.12M | |
| 2025-03-14 | 2025-03-07 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $60.62 | -17.1K | 485.6K | -3% | -$1.03M | |
| 2025-03-04 | 2025-02-28 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $61.89 | -12.2K | 502.7K | -2% | -$756.0K | |
| M | 2025-02-18 | 2025-02-12 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | A - Grant | $0.00 | +152.3K | 522.7K | +41% | $0 |
| 2025-02-18 | 2025-02-14 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $58.92 | -7,799 | 514.9K | -1% | -$459.5K | |
| DM | 2024-11-27 | 2024-11-26 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | S - Sale+OE | $57.99 | -33.5K | 370.4K | -8% | -$1.94M |
| D | 2024-11-27 | 2024-11-26 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | M - OptEx | $29.00 | +30.0K | 403.9K | +8% | +$870.0K |
| 2024-09-10 | 2024-09-08 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $60.51 | -3,646 | 373.9K | -1.0% | -$220.6K | |
| 2024-05-16 | 2024-05-14 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | S - Sale | $66.10 | -16.7K | 377.5K | -4% | -$1.10M | |
| 2024-03-25 | 2024-03-23 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $69.58 | -17.5K | 394.2K | -4% | -$1.21M | |
| M | 2024-03-08 | 2024-03-06+ | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | S - Sale | $66.10 | -45.3K | 445.0K | -9% | -$2.99M |
| 2024-03-08 | 2024-03-07 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $66.71 | -17.1K | 427.9K | -4% | -$1.14M | |
| 2024-03-01 | 2024-02-29 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $67.67 | -10.0K | 473.9K | -2% | -$677.6K | |
| M | 2024-02-16 | 2024-02-14 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | A - Grant | $0.00 | +134.2K | 484.0K | +38% | $0 |
| 2023-09-11 | 2023-09-08 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $61.94 | -3,646 | 349.7K | -1% | -$225.8K | |
| D | 2023-08-15 | 2023-08-15 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | M - OptEx | $29.00 | +11.6K | 365.0K | +3% | +$336.9K |
| DM | 2023-08-15 | 2023-08-11+ | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | S - Sale+OE | $58.32 | -68.3K | 353.4K | -16% | -$3.98M |
| M | 2023-04-04 | 2023-02-28 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | A - Grant | $0.00 | +159.2K | 346.4K | +85% | $0 |
| 2023-03-27 | 2023-03-23 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $37.82 | -17.5K | 250.8K | -7% | -$660.1K | |
| M | 2023-03-09 | 2023-03-07 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $44.23 | -13.7K | 268.3K | -5% | -$604.3K |
| 2022-09-12 | 2022-09-08 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $37.61 | -3,646 | 282.0K | -1% | -$137.1K | |
| 2022-04-29 | 2022-04-27 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | A - Grant | $0.00 | +33.4K | 285.6K | +13% | $0 | |
| 2022-03-28 | 2022-03-24 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | A - Grant | $0.00 | +100.1K | 252.3K | +66% | $0 | |
| 2022-03-25 | 2022-03-23 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $27.03 | -17.5K | 152.2K | -10% | -$471.8K | |
| 2022-03-23 | 2022-03-21 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | P - Purchase | $27.69 | +7,224 | 169.7K | +4% | +$200.0K | |
| 2021-09-10 | 2021-09-08 | ANIP | ANI PHARMACEUTICALS INC | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $28.20 | -2,577 | 162.4K | -2% | -$72.7K |
Purchase Sale Sale after option exercise All abbreviations